Revenue Breakdown
Composition ()
No data
Revenue Streams
Illumina Inc (ILMN) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Consumables, accounting for 75.3% of total sales, equivalent to $816.00M. Other significant revenue streams include Services and Other revenue and Instruments. Understanding this composition is critical for investors evaluating how ILMN navigates market cycles within the Advanced Medical Equipment & Technology industry.
Profitability & Margins
Evaluating the bottom line, Illumina Inc maintains a gross margin of 65.49%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 18.55%, while the net margin is 28.82%. These profitability ratios, combined with a Return on Equity (ROE) of 33.36%, provide a clear picture of how effectively ILMN converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, ILMN competes directly with industry leaders such as EXAS and ZBH. With a market capitalization of $20.32B, it holds a leading position in the sector. When comparing efficiency, ILMN's gross margin of 65.49% stands against EXAS's 70.11% and ZBH's 56.77%. Such benchmarking helps identify whether Illumina Inc is trading at a premium or discount relative to its financial performance.
